EDIT HUBERT BURDA MED SAS - PARIS : revenue, balance sheet and financial ratios

EDIT HUBERT BURDA MED SAS - PARIS is a French company founded 20 years ago, specialized in the sector Édition de revues et périodiques. Based in MONTROUGE (92120), this company of category PME shows in 2024 a revenue of 7.6 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - EDIT HUBERT BURDA MED SAS - PARIS (SIREN 484026067)
Indicator 2024 2023 2022 2021 2020 2019 2018 2017 2016
Revenue 7 625 811 € 8 695 312 € 10 691 171 € 12 098 856 € 8 895 657 € 9 509 947 € 9 916 784 € 8 398 225 € 8 614 720 €
Net income 109 529 € 66 504 € -396 750 € 34 654 € -698 388 € 168 608 € 115 653 € 101 303 € 176 884 €
EBITDA 712 511 € 1 092 161 € 740 269 € 1 410 211 € 733 543 € 819 351 € 833 412 € 571 237 € 651 657 €
Net margin 1.4% 0.8% -3.7% 0.3% -7.9% 1.8% 1.2% 1.2% 2.1%

Revenue and income statement

In 2024, EDIT HUBERT BURDA MED SAS - PARIS achieves revenue of 7.6 M€. Activity remains stable over the period (CAGR: -1.5%). Significant drop of -12% vs 2023. After deducting consumption (398 k€), gross margin stands at 7.2 M€, i.e. a rate of 95%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 713 k€, representing 9.3% of revenue. Warning negative scissor effect: despite revenue change (-12%), EBITDA varies by -35%, reducing margin by 3.2 pts. This reflects costs rising faster than revenue. This level of operating margin is satisfactory for the sector. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 110 k€, i.e. 1.4% of revenue. This profit can be retained or distributed to shareholders.

Revenue (2024) ?
Revenue
Definition
Total amount of sales of goods and services made by the company.
Formula
Sales of goods + Sold production

7 625 811 €

Gross margin (2024) ?
Gross margin
Definition
Difference between revenue and cost of goods sold.
Formula
Revenue - Cost of goods consumed

7 227 642 €

EBITDA (2024) ?
Gross Operating Surplus (EBITDA)
Definition
Resources generated by current operations, before depreciation and financial expenses.
Formula
Value added - Personnel expenses - Taxes
Interpretation
Positive = profitable activity

712 511 €

EBIT (2024) ?
EBIT (Operating Income)
Definition
Operating income, including depreciation and provisions.
Formula
EBITDA - Depreciation and provisions + Reversals

115 750 €

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

109 529 €

EBITDA margin (2024) ?
EBITDA margin
Definition
Measures the company's operating profitability.
Formula
(EBE / CA) x 100
Interpretation
> 10% : Good profitability
5-10% : Average
< 5% : Low

9.3%

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at -0%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches -12%. Low autonomy: the company heavily depends on external financing (banks, suppliers).

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

-0.242%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

-12.481%

Cash flow / Revenue (2024) ?
Cash flow / Revenue
Definition
Self-financing capacity relative to revenue.
Formula
(CAF / CA) x 100
Interpretation
The higher the ratio, the more cash the company generates

-8.687%

Repayment capacity (2024) ?
Repayment capacity
Definition
Number of years needed to repay debts with cash flow.
Formula
Financial debt / Cash flow
Interpretation
< 3 years : Excellent
3-5 years : Fair
> 5 years : Warning

-0.001

Solvency indicators evolution
EDIT HUBERT BURDA MED SAS - PARIS

Sector positioning

Debt ratio
-0.24 2024
2022
2023
2024
Q1: 0.0
Med: 0.16
Q3: 24.75
Excellent

In 2024, the debt ratio of EDIT HUBERT BURDA MED SAS... (-0.24) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.

Financial autonomy
-12.48% 2024
2022
2023
2024
Q1: 0.3%
Med: 30.06%
Q3: 58.7%
Average

In 2024, the financial autonomy of EDIT HUBERT BURDA MED SAS... (-12.5%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Repayment capacity
-0.0 years 2024
2022
2023
2024
Q1: 0.0 years
Med: 0.0 years
Q3: 0.28 years
Excellent

In 2024, the repayment capacity of EDIT HUBERT BURDA MED SAS... (-0.00) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 105.77. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months. The interest coverage ratio (= EBIT / Interest expenses) is 4.7x. Financial charges are adequately covered by operations.

Liquidity ratio (2024) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

105.765

Interest coverage (2024) ?
Interest coverage
Definition
Ability to cover interest charges with operating income.
Formula
EBIT / Interest expenses
Interpretation
> 3 : Comfortable
1.5-3 : Acceptable
< 1.5 : Risk

4.66

Liquidity indicators evolution
EDIT HUBERT BURDA MED SAS - PARIS

Sector positioning

Liquidity ratio
105.77 2024
2022
2023
2024
Q1: 113.84
Med: 201.96
Q3: 402.09
Watch

In 2024, the liquidity ratio of EDIT HUBERT BURDA MED SAS... (105.77) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.

Interest coverage
4.66x 2024
2022
2023
2024
Q1: 0.0x
Med: 0.0x
Q3: 0.38x
Excellent +50 pts over 3 years

In 2024, the interest coverage of EDIT HUBERT BURDA MED SAS... (4.7x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 40 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 51 days. Favorable situation: supplier credit is longer than customer credit by 11 days. Overall, WCR represents 13 days of revenue, i.e. 283 k€ to permanently finance. Notable WCR improvement over the period (-22%), freeing up cash.

Operating WCR (2024) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

283 375 €

Customer credit (2024) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

40 j

Supplier credit (2024) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

51 j

Inventory turnover (2024) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR in days of revenue (2024) ?
WCR in days of revenue
Definition
Expresses working capital requirement in days of revenue.
Formula
(Operating WCR / Revenue) x 360
Interpretation
The fewer days, the better the working capital management

13 j

WCR and payment terms evolution
EDIT HUBERT BURDA MED SAS - PARIS

Positioning of EDIT HUBERT BURDA MED SAS - PARIS in its sector

Comparison with sector Édition de revues et périodiques

Valuation estimate

Based on 67 transactions of similar company sales (all years), the value of EDIT HUBERT BURDA MED SAS - PARIS is estimated at 871 747 € (range 494 188€ - 3 414 967€). With an EBITDA of 712 511€, the sector multiple of 1.1x is applied. The price/revenue ratio is 0.16x (conservative valuation). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Medium reliability: estimate to be confirmed with in-depth analysis.

Estimated enterprise value 2024
67 tx
494k€ 871k€ 3414k€
871 747 € Range: 494 188€ - 3 414 967€
NAF 5 all-time

Valuation detail by method

Ajustez les pondérations selon votre analyse

EBITDA Multiple 50%
712 511 € × 1.1x
Estimation 752 054 €
427 615€ - 4 334 926€
Revenue Multiple 30%
7 625 811 € × 0.16x
Estimation 1 254 076 €
854 798€ - 3 469 595€
Net Income Multiple 20%
109 529 € × 5.5x
Estimation 597 488 €
119 709€ - 1 033 130€
How is this estimate calculated?

This estimate is based on the analysis of 67 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Édition de revues et périodiques)

Compare EDIT HUBERT BURDA MED SAS - PARIS with other companies in the same sector:

Voir toutes les statistiques du secteur Édition de revues et périodiques

Frequently asked questions about EDIT HUBERT BURDA MED SAS - PARIS

What is the revenue of EDIT HUBERT BURDA MED SAS - PARIS ?

The revenue of EDIT HUBERT BURDA MED SAS - PARIS in 2024 is 7.6 M€.

Is EDIT HUBERT BURDA MED SAS - PARIS profitable?

Yes, EDIT HUBERT BURDA MED SAS - PARIS generated a net profit of 110 k€ in 2024.

Where is the headquarters of EDIT HUBERT BURDA MED SAS - PARIS ?

The headquarters of EDIT HUBERT BURDA MED SAS - PARIS is located in MONTROUGE (92120), in the department Hauts-de-Seine.

Where to find the tax return of EDIT HUBERT BURDA MED SAS - PARIS ?

The tax return of EDIT HUBERT BURDA MED SAS - PARIS is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does EDIT HUBERT BURDA MED SAS - PARIS operate?

EDIT HUBERT BURDA MED SAS - PARIS operates in the sector Édition de revues et périodiques (NAF code 58.14Z). See the 'Sector positioning' section above to compare the company with its competitors.